Sepsis | Neutropenic Fever, Inflammatory Markers and Sepsis in Haematological Patients
Sepsis research study
What is the primary objective of this study?
The aim of this study is to find out whether inflammation markers including cardiac markers
have predictive value in evaluation of pathogenesis of sepsis in neutropenic haematological
Who is eligible to participate?
- diagnosis: acute myeloid leukaemia
- age under 70 years
- neutropenic fever
- age above 70 years
- no neutropenic fever
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Other:Severe sepsis vs. non-severe sepsisTo compare these two groups
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
Neutropenic patientsAdult AML and ASCT patients with neutropenic fever.
Start Date: December 2006
Completed Date: January 1, 2019
Primary Outcome: This study evaluates epidemiology, microbiology and outcome of neutropenic fever and severe sepsis in haematological patients with special reference to the kinetics of inflammatory markers.
Study sponsors, principal investigator, and references
Principal Investigator: Esa Jantunen, M.D, PhD
Lead Sponsor: Kuopio University Hospital